School of Medicine
Showing 11-20 of 86 Results
-
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Christina Bradshaw
Clinical Assistant Professor, Medicine - Nephrology
Current Research and Scholarly InterestsDr. Bradshaw is interested in studying counseling practices and transitions of care among persons with advanced chronic kidney disease and end-stage renal disease in low- and middle-income countries.
-
Brian Brady
Clinical Associate Professor, Medicine - Nephrology
BioDr. Brady is a fellowship-trained nephrologist with board certification in nephrology and in internal medicine. He is a clinical assistant professor in the Department of Medicine, Division of Nephrology, at Stanford University School of Medicine.
He provides care at the Stanford Health Care Boswell Kidney Clinic as well as the Stanford Health Care Kidney Clinic in Emeryville.
Dr. Brady is particularly interested in the management of patients with chronic kidney disease (CKD). He also treats end-stage kidney disease, hypertension, kidney stones, glomerular disease and other kidney related conditions.
His research in value-based health care focuses on methods to improve care delivery for patients with CKD and end-stage kidney disease (ESKD). He has received funding for his research from sources including the National Institutes of Health.
Dr. Brady has published his research findings in JAMA Internal Medicine the Journal of the American Society of Nephrology, and elsewhere.
He has presented invited talks on high-value care delivery to policy makers on Capitol Hill in Washington, DC. He also has made presentations to his peers at national, regional, and local meetings of kidney disease specialists.
He has delivered lectures to the Institute for Healthcare Improvement National Forum, Satellite Healthcare Home Dialysis Academy, and other meetings. He has shared his insights in presentations to faculty and students in the Division of Nephrology at Peking Union Medical College in Beijing, China.
Dr. Brady is a member of the American Society of Nephrology, International Society of Nephrology, and American College of Physicians. -
Stephan Busque
Professor of Surgery (Abdominal Transplantation), and by courtesy, of Medicine (Nephrology)
Current Research and Scholarly InterestsMy research interest is focused on the improvement of clinical immunosuppression. I am involved in the evaluation of new immunosuppressive drugs, potentially more efficacious or less toxic. My ultimate goal is to achieve tolerance, a state that would obviate the need for any drugs. I am an investigator part of a multidisciplinary tolerance induction project using total lymphoid irradiation and donor hematopoietic stem cells infusion after living donor kidney transplantation.
-
Tara I. Chang
Stanford University Professor of Nephrology
Current Research and Scholarly InterestsMy research focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with chronic kidney disease, with the long-term goal of improving cardiovascular outcomes in these high-risk patients.
-
Xingxing Shelley Cheng
Assistant Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation) and of Health Policy
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) the costs, effectiveness, and implementation of work-up before kidney transplantation, including pretransplant cardiovascular screening;
2) ethics of and decision-making in in multi-organ transplantation.
